Dr. Zaid Maayah’s research focuses on understanding the mechanisms underlying cardiovascular damage induced by chemotherapy and sepsis, two critical factors that significantly impact patient health. In the realm of cardio-oncology, his work explores how chemotherapy agents, while effective in treating cancer, can lead to long-term cardiovascular complications, including heart failure and other cardiac dysfunctions. Through his studies, Dr. Maayah aims to uncover the molecular pathways that contribute to these chemotherapy-induced damages, with the goal of developing therapeutic strategies to prevent or mitigate these effects. Additionally, his research extends to sepsis-induced cardiovascular problems, investigating how systemic inflammation during sepsis disrupts heart function and contributes to the high morbidity and mortality associated with this condition. By elucidating these complex interactions, Dr. Maayah seeks to identify novel biomarkers and therapeutic targets for improving cardiovascular outcomes in both cancer and sepsis patients.